GlaxoSmithKline teams with Vir Biotechnology to develop coronavirus vaccine, treatments By: Philadelphia Business Journal via Business Journals April 06, 2020 at 10:11 AM EDT GSK also plans to invest $250 million in the San Francisco-based biotechnology company. Read More >>